SOX4 and cancer: Further, the association between mRNA expression and clinical outcome was analyzed to determine the prognostic value of SOX4 expression in patients with various cancers, using the online survival analysis tools such as the Kaplan–Meier plotter (Balazs Gyorffy, Budapest, Hungary), PrognoScan (Kyushu Institute Technology, Kyushu, Japan), and R2 databases (the Academic Medical Center (AMC), Amsterdam, the Netherlands).